Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas.

Authors :: Candon S
Lemee V
Leveque E
Etancelin P
Paquin C
Carette M
Contentin N
Bobee V
Alani M
Cardinael N
Lepretre S
Camus V
Bouclet F
Boulet E
Menard AL
Lanic H
Stamatoullas A
Lemasle E
Pepin LF
Richard D
Dubois S
Tilly H
Dalleac A
Plantier JC
Etienne M
Jardin F
Source :: Haematologica [Haematologica] 2022 Mar 01; Vol. 107 (3), pp. 755-758. Date of Electronic Publication: 2022 Mar 01.
Publication Year :: 2022

Subjects :: Antibodies, Monoclonal therapeutic use
Antibodies, Viral
BNT162 Vaccine
Humans
Immunity, Cellular
Lymphoma, B-Cell drug therapy
Vaccines

Full Text Access

Tools